LCS
DNMR

Levin Capital Strategies’s Danimer Scientific, Inc. DNMR Stock Holding History

Levin Capital Strategies’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,000
Closed -$654K – 413
2021
Q3 		$654K Buy
+1,000
New +$735K 0.07% 136

Other funds holding DNMR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ZIM
Zacks Investment Management Chicago, Illinois $12.5B AUM 29.36% 1-Year Est. Return

Levin Capital Strategies's DNMR Position: Q2 2024 in Review

Levin Capital Strategies sold out of Danimer Scientific, Inc. (DNMR) in Q2 2024, closing a stake of 1,338 shares — an estimated $58.3K sold.

Levin Capital Strategies first reported a position in DNMR in Q4 2020 and held it in 11 quarters. The position peaked at $238K in Q2 2021. 139 funds tracked by Wall St. Rank hold DNMR as of Q2 2024.

  • Levin Capital Strategies reported no remaining Danimer Scientific, Inc. position as of Q2 2024 after selling out during the quarter.
  • Levin Capital Strategies sold 1,338 Danimer Scientific, Inc. shares in Q2 2024, an estimated $58.3K.
  • Levin Capital Strategies first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 11 quarters.
  • Levin Capital Strategies's Danimer Scientific, Inc. position peaked at $238K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2024.

Based on Levin Capital Strategies's 13F filing for Q2 2024, filed 7 Aug 2024.